A prospective cohort study involving 100000 subjects found that the risk of breast cancer increased by 25% (HR=1.25, 95% CI 1.06-1.47) and the risk of prostate cancer increased by 31% (HR=1.31, 95% CI 1.09-1.57) in the highest quintile of IGF-1
Access to Proven Medications - We offer trusted prescription options, including: Semaglutide and Tirzepatide
1 2 3 4 5 6 7 8 9 10 11 12 13 "Drug Trials Snapshots: Emgality"
Home Medical news & Guidelines Anesthesiology Cardiology and CTVS Critical Care Dentistry Dermatology Diabetes and Endocrinology ENT Gastroenterology Medicine Nephrology Neurology Obstretics-Gynaecology Oncology Ophthalmology Orthopaedics Pediatrics-Neonatology Psychiatry Pulmonology Radiology Surgery Urology Laboratory Medicine Diet Nursing Paramedical Physiotherapy Health news Fact Check Bone Health Fact Check Brain Health Fact Check Cancer Related Fact Check Child Care Fact Check Dental and oral health fact check Diabetes and metabolic health fact check Diet and Nutrition Fact Check Eye and ENT Care Fact Check Fitness fact check Gut health fact check Heart health fact check Kidney health fact check Medical education fact check Men's health fact check Respiratory fact check Skin and hair care fact check Vaccine and Immunization fact check Women's health fact check AYUSH State News Andaman and Nicobar Islands Andhra Pradesh Arunachal Pradesh Assam Bihar Chandigarh Chattisgarh Dadra and Nagar Haveli Daman and Diu Delhi Goa Gujarat Haryana Himachal Pradesh Jammu & Kashmir Jharkhand Karnataka Kerala Ladakh Lakshadweep Madhya Pradesh Maharashtra Manipur Meghalaya Mizoram Nagaland Odisha Puducherry Punjab Rajasthan Sikkim Tamil Nadu Telangana Tripura Uttar Pradesh Uttrakhand West Bengal Medical Education Industry GLP-1 Drugs Improve Metabolic Outcomes in Cushing's Syndrome Without Hormonal Harm: Study Researchers have discovered in a new study that among patients with Cushing's syndrome, treatment with GLP-1 drugs led to significant weight loss and better glycemic control
Glutamateglutamine cycling Biochemical pathway that describes the uptake and conversion of glutamate to glutamine by astrocytes and the subsequent transfer of glutamine back to neurons for conversion to glutamate
The clinicopathological and molecular associations of PD-L1 expression in non-small cell lung cancer: analysis of a series of 10,005 cases tested with the 22c3 assay
